ES521246A0 - Un procedimiento para la obtencion de nuevos derivados de cefalosporina. - Google Patents

Un procedimiento para la obtencion de nuevos derivados de cefalosporina.

Info

Publication number
ES521246A0
ES521246A0 ES521246A ES521246A ES521246A0 ES 521246 A0 ES521246 A0 ES 521246A0 ES 521246 A ES521246 A ES 521246A ES 521246 A ES521246 A ES 521246A ES 521246 A0 ES521246 A0 ES 521246A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining
cephalosporin derivatives
new cephalosporin
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521246A
Other languages
English (en)
Spanish (es)
Other versions
ES8501407A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57057010A external-priority patent/JPS58174386A/ja
Priority claimed from JP57132501A external-priority patent/JPS5921695A/ja
Priority claimed from JP57193607A external-priority patent/JPS5982390A/ja
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of ES8501407A1 publication Critical patent/ES8501407A1/es
Publication of ES521246A0 publication Critical patent/ES521246A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES521246A 1982-04-06 1983-04-05 Un procedimiento para la obtencion de nuevos derivados de cefalosporina. Granted ES521246A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP57057010A JPS58174386A (ja) 1982-04-06 1982-04-06 セフアロスポリン誘導体
JP57132501A JPS5921695A (ja) 1982-07-29 1982-07-29 セフアロスポリン誘導体
JP57193607A JPS5982390A (ja) 1982-11-04 1982-11-04 セフアロスポリン誘導体

Publications (2)

Publication Number Publication Date
ES8501407A1 ES8501407A1 (es) 1984-12-01
ES521246A0 true ES521246A0 (es) 1984-12-01

Family

ID=27296108

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521246A Granted ES521246A0 (es) 1982-04-06 1983-04-05 Un procedimiento para la obtencion de nuevos derivados de cefalosporina.

Country Status (10)

Country Link
US (1) US4603198A (enrdf_load_html_response)
EP (1) EP0091130B1 (enrdf_load_html_response)
KR (1) KR840004438A (enrdf_load_html_response)
AU (1) AU550462B2 (enrdf_load_html_response)
CA (1) CA1215970A (enrdf_load_html_response)
DE (1) DE3370801D1 (enrdf_load_html_response)
ES (1) ES521246A0 (enrdf_load_html_response)
GR (1) GR78176B (enrdf_load_html_response)
PH (1) PH19163A (enrdf_load_html_response)
YU (1) YU79383A (enrdf_load_html_response)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0157073B1 (ko) * 1992-10-01 1998-11-16 김태훈 세팔로스포린 유도체 및 그의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
FR2432521A1 (fr) * 1978-03-31 1980-02-29 Roussel Uclaf Nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
GB2029823A (en) * 1978-05-26 1980-03-26 Glaxo Group Ltd Cephalosporin Antibiotics
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
GB2028305A (en) * 1978-08-03 1980-03-05 Hoechst Ag Cephem derivatives and processes for their manufacture
US4271157A (en) * 1980-02-28 1981-06-02 E. R. Squibb & Sons, Inc. Imidazole derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GB2061276B (en) * 1979-10-25 1983-05-25 Squibb & Sons Inc Imidazole and tetrazole derivatives of 7-((2-amino-4-thiazolyl)-oximino)cephalosporins
JPS5677287A (en) * 1979-10-25 1981-06-25 Squibb & Sons Inc Imidazole and tetrazole derivative of aminothiazolylloxyiminocephalosporin

Also Published As

Publication number Publication date
GR78176B (enrdf_load_html_response) 1984-09-26
KR840004438A (ko) 1984-10-15
EP0091130A2 (en) 1983-10-12
EP0091130B1 (en) 1987-04-08
EP0091130A3 (en) 1984-07-25
ES8501407A1 (es) 1984-12-01
CA1215970A (en) 1986-12-30
US4603198A (en) 1986-07-29
AU550462B2 (en) 1986-03-20
YU79383A (en) 1986-04-30
AU1318483A (en) 1983-10-13
PH19163A (en) 1986-01-16
DE3370801D1 (en) 1987-05-14

Similar Documents

Publication Publication Date Title
ES528630A0 (es) Un procedimiento para la obtencion de derivados de hexahidro-3-oxo-piridinas.
ES505923A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES520132A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo.
ES527661A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES550369A0 (es) Un procedimiento para la fabricacion de derivados de cefalosporina.
ES510307A0 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES515548A0 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES542013A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES549498A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES520224A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES528079A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES506142A0 (es) Un procedimiento para la preparacion de nuevos acilderivadosde cefalosporina
ES533389A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES521955A0 (es) Un procedimiento para preparar derivados de cefalosporina.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES534269A0 (es) Un procedimiento para la preparacion de nuevos derivados de difeniletanona.